When a fixed regulatory deadline meets withheld evidence and shifting interpretations, questions follow. This open letter examines how the UK Food Standards Agency has applied its CBD novel foods rules—and whether those decisions can be properly scrutinised.

With a proposed UK–EU Sanitary and Phytosanitary (SPS) agreement potentially aligning food regulations, questions are emerging about where regulatory authority ultimately sits.